Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
α2,3-linked sialic acid–containing cell-surface glycoproteins are complex molecules where a sialic acid (typically N-acetylneuraminic acid) is attached to a galactose residue via an α2,3-glycosidic bond. These glycoproteins are essential components of the glycocalyx and serve as critical mediators of cell-cell communication and host-pathogen interactions (Varki, A. Glycobiology. 2008;18(10):770-790). They are famously recognized as the primary attachment receptors for avian influenza viruses, such as H5N1 and H7N9, which utilize the viral hemagglutinin protein to bind these specific linkages (Shinya, K., et al. Nature. 2006;440(7083):435-436). In humans, these receptors are predominantly expressed in the lower respiratory tract and the conjunctiva, explaining the tissue tropism and severe pathology of avian-origin infections (Nicholls, J. M., et al. Lancet. 2007;370(9602):1841-1843). Beyond infectious disease, altered expression of α2,3-sialylated glycans is a hallmark of many cancers, where they contribute to tumor cell migration, invasion, and evasion of the immune response (Pearce, O. M., & Laubli, H. Cancer Res. 2016;76(11):3121-3126). Therapeutic interventions include the development of sialidases, such as DAS181, which enzymatically strip these sialic acids from the cell surface to prevent viral entry (Triana-Baltzer, G. B., et al. PLoS One. 2013;8(2):e56963).
Enzymatic removal of terminal sialic acid residues from the host cell surface to prevent viral hemagglutinin binding and entry; inhibition of viral neuraminidase to prevent the cleavage of these linkages during viral egress.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on α2,3-linked sialic acid–containing cell-surface glycoproteins (α2,3-Sia).